PLASMA CELL DISORDER
Clinical trials for PLASMA CELL DISORDER explained in plain language.
Never miss a new study
Get alerted when new PLASMA CELL DISORDER trials appear
Sign up with your email to follow new studies for PLASMA CELL DISORDER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Thigh vs. belly: can a simple injection switch ease pain and expand access?
Symptom relief Recruiting nowThis study looks at whether injecting daratumumab into the thigh is as safe and effective as the usual belly injection for people with plasma cell disorders like multiple myeloma. Daratumumab is an approved drug that helps the immune system kill abnormal plasma cells. The goal is…
Matched conditions: PLASMA CELL DISORDER
Phase: PHASE1, PHASE2 • Sponsor: University of Maryland, Baltimore • Aim: Symptom relief
Last updated May 12, 2026 13:43 UTC
-
Firefighters' job may trigger hidden blood cancer risks
Knowledge-focused Recruiting nowThis study tracks 300 firefighters aged 40-49 with at least 5 years on the job to see if exposure to hazardous compounds increases early signs of blood cancers. Researchers will test for pre-cancerous conditions like clonal hematopoiesis and monoclonal gammopathy. The goal is to …
Matched conditions: PLASMA CELL DISORDER
Sponsor: Wake Forest University Health Sciences • Aim: Knowledge-focused
Last updated May 17, 2026 10:38 UTC